Quince Therapeutics Inc (NASDAQ:QNCX) has a beta value of 0.73 and has seen 1.05 million shares traded in the last trading session. The company, currently valued at $81.26M, closed the last trade at $1.96 per share which meant it lost -$0.12 on the day or -5.77% during that session. The QNCX stock price is -9.18% off its 52-week high price of $2.14 and 73.98% above the 52-week low of $0.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.42 million shares traded. The 3-month trading volume is 509.26K shares.
Quince Therapeutics Inc (NASDAQ:QNCX) trade information
Sporting -5.77% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the QNCX stock price touched $1.96 or saw a rise of 20.0%. Year-to-date, Quince Therapeutics Inc shares have moved 86.67%, while the 5-day performance has seen it change 10.11%. Over the past 30 days, the shares of Quince Therapeutics Inc (NASDAQ:QNCX) have changed 64.71%. Short interest in the company has seen 2.35 million shares shorted with days to cover at 2.27.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Quince Therapeutics Inc (QNCX) estimates and forecasts
The company’s shares have gained 130.62% over the past 6 months.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -12.64% over the past 5 years.
QNCX Dividends
Quince Therapeutics Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Quince Therapeutics Inc (NASDAQ:QNCX)’s Major holders
Insiders own 13.74% of the company shares, while shares held by institutions stand at 25.53% with a share float percentage of 29.60%. Investors are also buoyed by the number of investors in a company, with Quince Therapeutics Inc having a total of 50.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . As of Jun 30, 2024 , the former fund manager holds about 1.93% shares in the company for having 847.96 shares of worth $1.66 million while later fund manager owns 345.53 shares of worth $0.68 million as of Jun 30, 2024 , which makes it owner of about 0.79% of company’s outstanding stock.
